A
Arnab Chatterjee
Researcher at Tata Consultancy Services
Publications - 165
Citations - 5916
Arnab Chatterjee is an academic researcher from Tata Consultancy Services. The author has contributed to research in topics: Population & Kinetic exchange models of markets. The author has an hindex of 34, co-authored 142 publications receiving 5149 citations. Previous affiliations of Arnab Chatterjee include Saha Institute of Nuclear Physics & Aalto University.
Papers
More filters
Posted Content
Annual Journal citation indices: a comparative study
TL;DR: The present work raises the question whether Impact factor, being one of these measures, is actually a nearly perfect index as claimed often, and investigates the distributions of the different indices which also behave similarly.
Posted Content
The Nobel Prize delay
Francesco Becattini,Arnab Chatterjee,Santo Fortunato,Marija Mitrović,Raj Kumar Pan,Pietro Della Briotta Parolo +5 more
TL;DR: The time lag between the publication of a Nobel discovery and the conferment of the prize has been rapidly increasing for all disciplines, especially for Physics, which means fundamental science is running out of groundbreaking discoveries.
Patent
Compounds for treatment of cystic fibrosis
TL;DR: In this paper, compounds, compositions, and methods of their use for the treatment of cystic fibrosis are described, as well as their compositions and their use in clinical trials.
Posted Content
Analyzing behavioral trends in community driven discussion platforms like Reddit
Sachin Thukral,Hardik Meisheri,Tushar Kataria,Aman Agarwal,Ishan Verma,Arnab Chatterjee,Lipika Dey +6 more
TL;DR: This study analyzes the statistical behavior of posts and modeling user interactions around them to understand how social media space has evolved over the years and provides interesting insights about a large number of inactive posts which fail to gather attention despite their authors exhibiting Cyborg-like behavior.
Patent
Liver x receptor agonists and uses thereof
Stephanie Pinkerton,Matthew S. Tremblay,Arnab Chatterjee,Bo Cheng,Reyna K. Lim V,Shan Yu,Peter G. Schultz +6 more
TL;DR: In this paper, antibody drug conjugates having an antibody or antibody fragment that binds a cell surface molecule on a target cell, wherein the target cell is a lymphocyte and a therapeutic agent that has a therapeutic effect in a subject in need thereof.